• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 期刊论文
  5. Outcome of gastric antral vascular ectasia and related anemia after orthotopic liver transplantation

Outcome of gastric antral vascular ectasia and related anemia after orthotopic liver transplantation

来源 :世界肝病学杂志:英文版(电子版) | 被引量 : 0次 | 上传用户：lyx2597758
【摘 要】
：
BACKGROUND Gastric antral vascular ectasia(GAVE)is a significant complication of cirrhosis.Numerous medical,surgical,and endoscopic treatment modalities have be
【作 者】
：
Saad Emhmed Ali Karim M Benraj 
【机 构】
：
DivisionofHospitalMedicine,DivisionofDigestiveDiseasesandNutrition
【出 处】
：
世界肝病学杂志:英文版(电子版)
【发表日期】
：
2020年11期
【关键词】
：
Liver cirrhosis Iron deficiency anemia End-stage liver disease GASTROSCOPY Gastr 
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
BACKGROUND Gastric antral vascular ectasia(GAVE)is a significant complication of cirrhosis.Numerous medical,surgical,and endoscopic treatment modalities have been proposed with varied satisfactory results.In a few small studies,GAVE and associated anemia
其他文献
Meeting report of the editorial board meeting for World Journal of Hepatology 2021
The 2021 online editorial board meeting of the World Journal of Hepatology(WJH)was held on January 16,2021.Xiang Li,Director of Production Office on behalf of t
期刊
WorldJournalofHepatologyBaishidengEditorialboardmeetingJournaldevelopme
Autophagy in liver diseases
Autophagy is the liver cell energy recycling system regulating a variety of homeostatic mechanisms.Damaged organelles,lipids and proteins are degraded in the ly
期刊
AUTOPHAGYLipophagyMITOPHAGYFattyliverdiseaseFIBROSISLiversinusoidalcell
Cannabis use history is associated with increased prevalence of ascites among patients with nonalcoh
BACKGROUND Recent studies have revealed the endocannabinoid system as a potential therapeutic target in the management of nonalcoholic fatty liver disease(NAFLD
期刊
NonalcoholicfattyliverdiseaseFattyliverCANNABISMarijuanauseLiverdiseas
Screening and identification of bioactive compounds from citrus against non-structural protein 3 pro
BACKGROUND Hepatitis C virus genotype 3a(HCV G3a)is highly prevalent in Pakistan.Due to the elevated cost of available Food and Drug Administration-approved dru
期刊
HepatitisCvirusgenotype3aNon-structuralprotein3proteaseFluorescenceres
Identification of key genes controlling cancer stem cell characteristics in gastric cancer
BACKGROUND Self-renewal of gastric cancer stem cells(GCSCs)is considered to be the underlying cause of the metastasis,drug resistance,and recurrence of gastric
期刊
GastriccancerCancerstemcellKeygeneTheCancerGenomeAtlasdatabaseWeight
Aceclofenac-induced hepatotoxicity:An ameliorative effect of Terminalia bellirica fruit and ellagic
BACKGROUND Aceclofenac(ACF),a widely used nonsteroidal anti-inflammatory drug,has been associated with a number of severe cases of clinical hepatotoxicity.Termi
期刊
TerminaliabelliricaEllagicacidACECLOFENACHEPATOTOXICITYANTIOXIDANTHISTOPA
Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma(≤2 cm,
BACKGROUND In hepatocellular carcinoma(HCC),detection and treatment prior to growth beyond 2 cm are relevant as a larger tumor size is more frequently associate
期刊
HepatocellularcarcinomaAFPPIVKA-IIBarcelonaclinicalstageTumormarkers
Paraneoplastic syndromes in cholangiocarcinoma
Paraneoplastic syndromes are the symptoms or signs which result from damage to tissues that are distant from the site of malignancy,due to complex interactions
期刊
CHOLANGIOCARCINOMAParaneoplasticsyndromeMALIGNANCYImmunesystemBiliarytree
Circulating miR-21-5p level has limited prognostic value in patients with hepatocellular carcinoma a
BACKGROUND MicroRNAs(miRNAs)have been suggested as biomarkers for malignant diseases including hepatocellular carcinoma(HCC).Specifically,hsa-miR-21-5p(miR-21)i
期刊
HepatocellularcancerHepatocellularcarcinomaMicroRNAPROGNOSISmiR-21-5pRena
Hepatitis B surface antigen and hepatitis B core-related antigen kinetics after adding pegylated-int
BACKGROUND Hepatitis B e antigen-negative chronic hepatitis B patients under nucleos(t)ids analogues(NAs)rarely achieve hepatitis B surface antigen(HBsAg)loss.A
期刊
ChronichepatitisBHepatitisBeantigen-negativeHepatitisBsurfaceantigenH